MICHELLE STREU: Open Payments
NPI 1821284951 · TECUMSEH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,373 in 77 payments from 17 companies in 2025. Trend: 2023 $541 · 2024 $1,259 · 2025 $1,373
Food & beverage: $1,373
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 19 | $334 |
| Otsuka America Pharmaceutical, Inc. | 11 | $185 |
| Novo Nordisk Inc | 8 | $161 |
| ABBVIE INC. | 10 | $157 |
| AstraZeneca Pharmaceuticals LP | 6 | $105 |
| Lilly USA, LLC | 5 | $81 |
| Dexcom, Inc. | 4 | $70 |
| Vanda Pharmaceuticals Inc. | 3 | $69 |
| Exact Sciences Corporation | 3 | $51 |
| Boston Scientific Corporation | 1 | $27 |
Products named: REXULTI, ELIQUIS, VRAYLAR, PAXLOVID, AIRSUPRA, Rybelsus, NURTEC ODT, Dexcom G6 Transmitter.
Industry payments across MI — which companies pay providers there.
